UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
October 4, 2007
---------------
Date of Report (Date of earliest event reported)
PhotoMedex, Inc.
----------------
(Exact name of Registrant as specified in its charter)
Delaware 0-11635 59-2058100
-------- ------- ----------
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation) File Number) Identification No.)
147 Keystone Drive, Montgomeryville, Pennsylvania 18936
-------------------------------------------------------
(Address of principal executive offices)
(Zip Code)
(215) 619-3600
--------------
Registrant's telephone number, including area code
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[_] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Other Events.
Regulation FD Disclosure. On October 4, 2007, the Registrant announced that Blue
Cross and Blue Shield of Illinois, Blue Cross and Blue Shield of New Mexico,
Blue Cross and Blue Shield of Oklahoma and Blue Cross and Blue Shield of Texas,
all divisions of Health Care Service Corporation (HCSC) have adopted a medical
policy approving payment for medically necessary treatment of mild to moderate
psoriasis using the PhotoMedex XTRAC(R) laser system.
The Information contained herein and in the accompanying exhibit shall not
be incorporated by reference into any filing of the Registrant, whether made
before or after the date hereof, regardless of any general incorporation
language in such filing, unless expressly incorporated by specific reference to
such filing. The information in this report, including the exhibit hereto, shall
not be deemed to be "filed" for purposes of Section 16 of the Securities
Exchange Act of 1934, as amended, or otherwise subject to the liabilities of
that section or Sections 11 and 12 (a) (2) of the Securities Act of 1933, as
amended.
A copy of the press release issued by the Registrant concerning the
announcement is furnished herewith as Exhibit 99.1.
2
Item 9.01. Financial Statements and Exhibits.
(c) Exhibits.
99.1 Press Release, dated October 4, 2007.
3
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
PHOTOMEDEX, INC.
Dated: October 4, 2007 By: /s/ Jeffrey F. O'Donnell
---------------------------
Jeffrey F. O'Donnell
Chief Executive Officer
4
EXHIBIT INDEX
-------------
Exhibit Number Description
-------------- -----------
99.1 Press release, dated October 4, 2007.
5